Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-SCAI Antibody (R2S73)

Catalog #:   RHN86601 Specific References (12) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IHC, WB
Accession: Q8N9R8
Overview

Catalog No.

RHN86601

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IHC: 1:50-1:100, WB: 1:500-1:1000

Target

SCAI, Suppressor of cancer cell invasion protein, Protein SCAI, C9orf126

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q8N9R8

Applications

IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2S73

Data Image
  • Immunohistochemical
    Immunohistochemistry analysis of paraffin-embedded Human lung cancer using SCAI antibody.High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
  • Western blot
    Western blot analysis of SCAI in C6, 3T3 lysates using SCAI antibody.
References

Improvement of diabetes-induced spinal cord axon injury with taurine via nerve growth factor-dependent Akt/mTOR pathway., PMID:38637413

Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI., PMID:38588930

Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer., PMID:33751752

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial., PMID:33211076

In silico pharmacogenetic approach: The natalizumab case study., PMID:28733203

Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer., PMID:25622824

Strategies to design inhibitors of Clostridium botulinum neurotoxins., PMID:17346211

Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells., PMID:16224047

The complication., PMID:14571502

Quantifying the local reliability of a sequence alignment., PMID:9005433

Streptococcus pneumoniae type 3 encodes a protein highly similar to the human glutamate decarboxylase (GAD65)., PMID:8566695

Isolation and in vitro expression of the ricin A-chain gene: effect of deletions on biological activity., PMID:2922291

Datasheet

Document Download

Anti-SCAI Antibody (R2S73).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-SCAI Antibody (R2S73) [RHN86601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only